George J. Leslie

3.0k citations

27 papers · 2.5k indexed · 1 hit paper · h-index 20

Co-authors: Robert W. Doms Stefan Pöhlmann Frédéric Baribaud Benhur Lee Elizabeth J. Soilleux Nicholas Coleman Donald S. Pijak Virginia M.‐Y. Lee
Topics: HIV Research and Treatment (22 papers)Immune Cell Function and Interaction (18 papers)Immunotherapy and Immune Responses (9 papers)
Cited by: Virology Immunology Infectious Diseases
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Medicine
Partner nations: United States Germany United Kingdom

In The Last Decade

George J. Leslie

27 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR

2003 309 citations Stefan Pöhlmann, Jie Zhang et al. Journal of Virology profile →

Peers

Countries citing papers authored by George J. Leslie

Since Specialization

Citations

This map shows the geographic impact of George J. Leslie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George J. Leslie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George J. Leslie more than expected).

Fields of papers citing papers by George J. Leslie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George J. Leslie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George J. Leslie. The network helps show where George J. Leslie may publish in the future.

Co-authorship network of co-authors of George J. Leslie

This figure shows the co-authorship network connecting the top 25 collaborators of George J. Leslie. A scholar is included among the top collaborators of George J. Leslie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George J. Leslie. George J. Leslie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HIV-1–Infected CD4+ T Cells Present MHC Class II–Restricted Epitope via Endogenous Processing 2022 ·The Journal of Immunology ·(unknown),Gavin I. Ellis,George J. Leslie,(unknown),James L. Riley,James A. Hoxie,Laurence C. Eisenlohr	4
2	Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo 2020 ·Nature Medicine ·Colby R. Maldini,Daniel T. Claiborne,(unknown),Tao Chen,(unknown),Xiaochuan Shan,Karen A. Power,Radiana Trifonova,(unknown),(unknown),Vladimir Vrbanac,(unknown),(unknown),George J. Leslie,James A. Hoxie,Christian L. Boutwell,James L. Riley,Todd M. Allen	76
3	Tetherin downmodulation by SIVmac Nef lost with the H196Q escape variant is restored by an upstream variant 2020 ·PLoS ONE ·Blake Schouest,George J. Leslie,James A. Hoxie,Nicholas J. Maness	1
4	Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus 2016 ·PLoS Pathogens ·George J. Leslie,Jianbin Wang,Max W. Richardson,Beth Haggarty,Kevin Hua,Jennifer Duong,Anthony Secreto,(unknown),Josephine Romano,(unknown),(unknown),Philip D. Gregory,Carl H. June,Michael J. Root,James L. Riley,Michael C. Holmes,James A. Hoxie	33
5	Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions 2013 ·Retrovirology ·Arangassery Rosemary Bastian,Mark Contarino,(unknown),Rachna Aneja,Diogo Rodrigo Magalhães Moreira,Kevin J. Freedman,Karyn McFadden,(unknown),(unknown),George J. Leslie,Jeffrey M. Jacobson,James A. Hoxie,Irwin Chaiken	27
6	Structure-Based Identification and Neutralization Mechanism of Tyrosine Sulfate Mimetics That Inhibit HIV-1 Entry 2011 ·ACS Chemical Biology ·Priyamvada Acharya,Cajetan Dogo‐Isonagie,Judith M. LaLonde,Son N. Lam,George J. Leslie,Mark K. Louder,Leah L. Frye,Asim K. Debnath,Jeremy R. Greenwood,Timothy S. Luongo,Loı̈c Martin,(unknown),James A. Hoxie,John R. Mascola,Carole A. Bewley,Peter D. Kwong	29
7	Characterization of a Human Immunodeficiency Virus Type 1 V3 Deletion Mutation That Confers Resistance to CCR5 Inhibitors and the Ability To Use Aplaviroc-Bound Receptor 2009 ·Journal of Virology ·Katrina M. Nolan,Gregory Q. Del Prete,Andrea P. O. Jordan,Beth Haggarty,Josephine Romano,George J. Leslie,James A. Hoxie	24
8	V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies 2007 ·PLoS Pathogens ·(unknown),(unknown),Beth Haggarty,(unknown),Katrina M. Nolan,(unknown),Josephine Romano,Andrea P. O. Jordan,George J. Leslie,Eric G. Meissner,Lishan Su,James A. Hoxie,Robert W. Doms	65
9	A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo 2006 ·Virology ·Stefan Pöhlmann,Jan Münch,(unknown),Jacqueline D. Reeves,Claas Otto,George J. Leslie,Heike Hofmann,Bridget A. Puffer,Frédéric Baribaud,Andrea Marzi,Thomas Gramberg,Zhiwei Chen,Nicole Stolte,Peter ten Haaft,Jonathan L. Heeney,Christiane Stahl‐Hennig,Kerstin Mätz‐Rensing,Thomas Schneider,Robert W. Doms,Frank Kirchhoff	3
10	Amino Acid 324 in the Simian Immunodeficiency Virus SIVmac V3 Loop Can Confer CD4 Independence and Modulate the Interaction with CCR5 and Alternative Coreceptors 2004 ·Journal of Virology ·Stefan Pöhlmann,Carl W. Davis,Silke Meister,George J. Leslie,Claas Otto,Jacqueline D. Reeves,Bridget A. Puffer,Armin Papkalla,Mandy Krumbiegel,Andrea Marzi,Steffen Lorenz,Jan Münch,Robert W. Doms,Frank Kirchhoff	21
11	Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNRbreakdown → 2003 ·Journal of Virology ·Stefan Pöhlmann,Jie Zhang,Frédéric Baribaud,Zhiwei Chen,George J. Leslie,George Lin,Angela Granelli‐Piperno,Robert W. Doms,Charles M. Rice,Jane A. McKeating	309
12	Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR 2002 ·Journal of Virology ·George Lin,Graham Simmons,Stefan Pöhlmann,Frédéric Baribaud,Houping Ni,George J. Leslie,Beth Haggarty,Paul Bates,Drew Weissman,James A. Hoxie,Robert W. Doms	209
13	Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro 2002 ·Journal of Leukocyte Biology ·Elizabeth J. Soilleux,Lesley S. Morris,George J. Leslie,Jihed Chehimi,Qi Luo,Ernest L. Levroney,John Trowsdale,Luis J. Montaner,Robert W. Doms,Drew Weissman,Nicholas Coleman,Benhur Lee	372
14	DC-SIGN Interactions with Human Immunodeficiency Virus: Virus Binding and Transfer Are Dissociable Functions 2001 ·Journal of Virology ·Stefan Pöhlmann,George J. Leslie,Terri G. Edwards,Todd S. Macfarlan,Jacqueline D. Reeves,(unknown),Frank Kirchhoff,Frédéric Baribaud,Robert W. Doms	56
15	DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunodeficiency Virus 2001 ·Journal of Virology ·Stefan Pöhlmann,Frédéric Baribaud,Benhur Lee,George J. Leslie,Melissa D. Sánchez,(unknown),Jan Münch,Frank Kirchhoff,Robert W. Doms	197
16	cisExpression of DC-SIGN Allows for More Efficient Entry of Human and Simian Immunodeficiency Viruses via CD4 and a Coreceptor 2001 ·Journal of Virology ·Benhur Lee,George J. Leslie,Elizabeth J. Soilleux,Una O’Doherty,Sarah Baik,Ernest L. Levroney,(unknown),William J. Swiggard,Nicholas Coleman,Michael H. Malim,Robert W. Doms	149
17	DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans 2001 ·Proceedings of the National Academy of Sciences ·Stefan Pöhlmann,Elizabeth J. Soilleux,Frédéric Baribaud,George J. Leslie,Lesley S. Morris,John Trowsdale,Benhur Lee,Nicholas Coleman,Robert W. Doms	276
18	Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme 2000 ·Journal of Biological Chemistry ·Jason T. Huse,Donald S. Pijak,George J. Leslie,Virginia M.‐Y. Lee,Robert W. Doms	345
19	Simian Immunodeficiency Virus Utilizes Human and Sooty Mangabey but Not Rhesus Macaque STRL33 for Efficient Entry 2000 ·Journal of Virology ·Stefan Pöhlmann,Benhur Lee,Silke Meister,Mandy Krumbiegel,George J. Leslie,Robert W. Doms,Frank Kirchhoff	34
20	Chief academic officers’ perceptions of the relationship between faculty research and undergraduate teaching 1998 ·Sociological Spectrum ·(unknown),(unknown),George J. Leslie	8

About George J. Leslie

George J. Leslie is a scholar working on Virology, Immunology and Infectious Diseases, having authored 27 papers that have together received 2.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (18 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Virology (923 citations), Immunology (1.2k citations) and Infectious Diseases (576 citations). George J. Leslie has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Robert W. Doms, Stefan Pöhlmann, Frédéric Baribaud, Benhur Lee, Elizabeth J. Soilleux, Nicholas Coleman, Donald S. Pijak, Virginia M.‐Y. Lee, Jason T. Huse and John Trowsdale. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact